abstract |
The present invention encompasses small molecule inhibitors of phosphatidylinositol 3-kinase (P13K), which are particularly associated with multiple cancers such as ovarian cancer, cervical cancer, breast cancer, colon cancer, rectal cancer and glioblastoma. Accordingly, the compounds of the present invention are useful for the treatment, prevention and / or inhibition of the above-mentioned diseases. |